Deerfield Capital Management

Deerfield Capital Management

Deerfield Capital Management

Follow us
Alexa global traffic share
Latest investments Show all
$65,000,000
Venture capital (Series B)
Ribon Therapeutics
$150,000,000
Venture capital (Series C)
Orchard Therapeutics
Team Size
1–10
Employees
Geographical Focus
Markets focus
Past year's investments

Deerfield Capital Management participated in fewer than 3 rounds over the past year

Latest rounds
  • Ribon Therapeutics: Venture capital (Series B) ($65M)
  • Orchard Therapeutics: Venture capital (Series C) ($150M)
  • Metacrine: Venture capital (Series C) ($65M)